Frederic Zenhausern, Ph.D., MBA, FNAI, FAIMBE

Frederic Zenhausern, Ph.D., MBA, FNAI, FAIMBE

Biography

Dr. Zenhausern’s role at the HonorHealth Research Institute has been to assist physicians in designing and conducting clinical translational studies. Dr. Zenhausern is also Endowed Chair Professor at the Department of Basic Medical Sciences, and Director of the Center for Applied NanoBioscience and Medicine (ANBM) at the University of Arizona College of Medicine–Phoenix. He is also Professor in Biomedical Engineering, Radiation Oncology, Clinical Translational Sciences and Translational Neurosciences. Prior to joining The University of Arizona, professor Zenhausern was Director of the Center for Applied NanoBioscience at ASU’s Biodesign Institute. While at ASU, he was R&D Director at the Flexible Display Center and Chief-Technical-Officer at ASU MacroTechnology Works. Dr. Zenhausern was also a tenured Professor with both the Electrical Engineering Department and the School of Materials and Chemical Engineering at ASU’s Ira A. Fulton School of Engineering.

Dr. Zenhausern is Professor at TGen, and Professor of Pharmaceutical Sciences at the University of Geneva, Switzerland. He has been a multiple startups entrepreneur after spending over a decade in industry at IBM T.J. Watson Research Center and Motorola Labs.

Dr. Zenhausern received his B.S. in Biochemistry from the University of Geneva, a MBA in Finance from Rutgers University, and his Ph.D. in Applied Physics from the Department of Condensed Physics Matter at the University of Geneva, Switzerland. Dr. Zenhausern has authored more than 100 peer-reviewed publications and more than 35 issued U.S. Patents. He is a Fellow of the U.S. National Academy of Inventors (NAI) and a Fellow of the American Institute of Medical and Biological Engineering (AIMBE).

Research Interests & Focus

Dr. Zenhausern’s research projects are sponsored by industry, foundations and federal agencies, highlighting the interdisciplinary and translational nature of his work.
His current areas of research comprise clinical translational projects across platform technologies, such as nanosystems for targeted drug deliveries, advanced radiotherapies, organ-on-chip and microfluidic devices for drug discoveries, point-of-care medical devices, bioassay development for broad applications in cancer biology, radiobiology, microbiome, neuroscience, molecular diagnostics, rural health, space medicine and new drug compounds and delivery systems for personalized medicine. His developments in other fields of healthcare delivery comprise technologies for health logistics, digital health, AI/ML computation.